HealthRx vs embody vs welludr: Prepaid, Flat or Locked?
Last updated: Sep 1, 2026
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Clinically checked Checked · Author: Top Weight Loss Research Team · Our review process
Some links on this page earn us a commission, which has no effect on how providers rank (our editorial independence).
Quick answer
HealthRx, embody and welludr sell the same compounded semaglutide under three different payment models. HealthRx takes the full year up front: $1,188 at checkout, which works out to $99/month, with overnight cold-chain shipping. embody bills $69 a month and lets you stop at any time. welludr also bills monthly, but its $49 rate requires a 12-month plan. It is the clearest comparison of commitment structures on the market, and the right choice comes down to one thing: how sure you are about the next 12 months.
Semaglutide from $69/mo, delivered in 1-2 days
Go to embody
Compounded semaglutide from $49/month and tirzepatide from $89/month
Go to welludrHow do HealthRx, embody, welludr compare?
Published prices and plan terms for all three providers, row by row, so the real differences are easy to spot.
| HealthRx | embody | welludr | |
|---|---|---|---|
| Semaglutide price | $99/mo, 12-month prepaid ($1,188 due at checkout) | $69/mo at every dose | $49/mo on a 12-month plan, any dose |
| Tirzepatide price | from $179/mo | $119/mo | $89/mo |
| Billing & contract | Prepaid for 12 months; whole year paid at checkout | Month-to-month, cancel whenever you like | Billed monthly; lowest rate needs a 12-month plan |
| Delivery | Free overnight cold-chain delivery, lot-tracked | Free in 1-2 days, tracked and insured | Free, discreet refills every 4 weeks |
| Care & support | Clinician reviews every request; care-team check-ins | Licensed doctors plus a medical director and nurses | A Medical Weight-Care Coach on every plan |
| Refund or guarantee | Free assessment, nothing to pay to start | 100% refund if a provider declines you | Weight-loss warranty (see site for terms) |
| Stands out for | LegitScript certification (cert. 50087439); 503A pharmacies | LegitScript certification; 503A pharmacy network | Board-certified specialists; 1M+ patients served |
Which one we recommend
If you are sure about the year and comfortable paying up front, HealthRx's prepaid $99 buys the best delivery in our ranking, overnight and lot-tracked. If you are sure about the year but prefer monthly bills, welludr's $49 rate on a 12-month plan is the lowest per-month price anywhere. If you aren't sure yet, start with embody ($69, no strings, refund if not approved) and look at the committed options again once the first few months answer the question. Starting flexible and committing later costs less than you might expect.
HealthRx vs embody vs welludr: common questions
Is HealthRx really $99 a month?
Yes, on a 12-month prepaid semaglutide plan: you pay $1,188 at checkout, which works out to $99/month and covers the clinician consult, overnight cold-chain shipping and dose adjustments. Tirzepatide plans start at $179/month. HealthRx holds LegitScript certification (cert. 50087439).
Which of the three is the lowest-risk way to start?
embody carries the least commitment risk: $69/month flat, cancel anytime, and a full refund if a provider doesn't approve you. That makes it a sensible first step if you are new to GLP-1 medication and want to confirm it suits you before committing to a year anywhere.
Which costs the least over a full year?
At listed semaglutide prices, welludr costs $588 a year ($49 x 12, billed monthly on a 12-month plan), embody $828 ($69 flat) and HealthRx $1,188 (prepaid up front). The extra you pay HealthRx covers overnight cold-chain delivery on every shipment.
Compare them in pairs
One-on-one matchups between each pair of these three providers.
References and clinical sources
The medication facts on this page rest on FDA guidance and peer-reviewed clinical trials, while prices and plan terms come from what each provider publishes. Use this page as general information, not medical advice, and speak with a licensed clinician before you start any weight loss treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)